Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Articles

Experts describe best practices for sterility assurance in parenteral drug manufacturing. This article contains bonus online-exclusive material.

Ensuring Sterility of Parenteral Products

Jim Greenwood is president and CEO of the Biotechnology Innovation Organization (BIO). He represented Pennsylvania’s 8thÂ district in the US House of Representatives from 1993 to 2005.

Sound policies are needed to govern the substitution of interchangeable biologics.

Prescribing Caution for Biosimilars

A Q&A with Tony Hitchcock, head of manufacturing at Cobra Biologics.

Viral Vaccine Manufacturing

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Russell Madsen, group leader of the Parenteral Drug Association (PDA) Filtration Interest Group, discusses technical and regulatory considerations in filtration for parenteral drug manufacturing

Filtration Critical Issue for Parenterals

Equipment suppliers are helping the pharmaceutical industry move towards adoption of continuous tablet production.

Making Strides in Continuous Tableting

Loss-in-weight feeders provide high accuracy for feeding powders.

Using a Gravimetric Feeder for Dosing Pharmaceutical Bulk Solids

Dow Chemical and Bend Research are developing and commercializing new materials for spray-dried dispersions that address technology gaps in manufacturability and delivery.

Collaboration Targets Advances in Spray-Dried Dispersion Solutions for Poorly Soluble Drugs

Matthieu Egloff, product director with ATMI LifeSciences, discusses the need for larger, special reactors that can provide the necessary conditions for the production of fragile cells on a larger scale.

New Reactor Technology Enables Larger Scale Manufacture of Fragile Cells

The growth in biologics drugs and vaccines is leading to greater demand for prefilled syringes, which provide greater safety and convenience for healthcare workers and patients.

Technology and Adoption of Prefilled Syringes Advance

Roche and BioLamina have entered into a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research. The collaboration will assess laminin-based in-vitro cell culture matrices that can offer physiological microenvironments for living cells.